Lihua Geng

Lihua Geng

Auto-generated profile, based on publicly available information

Lihua Geng

Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
DZDeng Zhenzhen
Deng Zhenzhen
YLYingjuan Liu
Yingjuan Liu
JWJing Wang
Jing Wang
SWSuhuang Wu
Suhuang Wu
LGLihua Geng
Lihua Geng
QZQuanbin Zhang
Quanbin Zhang
A variety of biologically active products have been isolated from Gracilariopsis lemaneiformis. In the present study, two novel angiotensin-converting enzyme (ACE) inhibitory peptides, FQIN [M(O)] CILR, and TGAPCR, were screened and identified from G. lemaneiformis protein hydrolysates by LC-MS/MS. The IC50 values of FQIN [M(O)] CILR and TGAPCR were 9.64 ± 0.36 μM and 23.94 ± 0.82 μM, respectively. In the stability study, both peptides showed stabilities of pH, temperature, simulated gastrointestinal digestion, and ACE hydrolysis. The Lineweaver–Burk plot showed that the two peptides were noncompetitive inhibitors of ACE. Molecular docking simulated the intermolecular interactions of two peptides and ACE, and the two peptides formed hydrogen bonds with the active pockets of ACE. However, FQIN [M(O)] CILR was more closely linked to the active pockets of ACE, thereby exerting better ACE inhibition. Spontaneously hypertensive rats (SHRs) were studied with an oral dose of 10 mg/kg body weight. Both peptides reduced systolic blood pressure (SBP) and diastolic blood pressure (DBP) in SHRs, of which FQIN [M(O)] CILR was able to reduce the systolic blood pressure by 34 mmHg (SBP) (p < 0.05). Therefore, FQIN [M(O)] CILR was an excellent ACE inhibitory peptide.

1 December 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
LGLihua Geng
Lihua Geng
WHWeicheng Hu
Weicheng Hu
YLYingjuan Liu
Yingjuan Liu
JWJing Wang
Jing Wang
QZQuanbin Zhang
Quanbin Zhang

6 March 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
YLYingjuan Liu
Yingjuan Liu
LGLihua Geng
Lihua Geng
JZJingjing Zhang
Jingjing Zhang
JWJing Wang
Jing Wang
QZQi Zhang
Qi Zhang
QZQuanbin Zhang
Quanbin Zhang
Parkinson’s disease (PD) is a neurodegenerative movement disorder that is caused by a selective loss of dopaminergic neurons. Current PD treatments provide symptomatic relief but do not prevent or decelerate disease progression. Previous studies have suggested that acetylated and phosphorylated porphyran, derived from Porphyra, produces a neuroprotective effect against 6-OHDA-induced damage. Due to its antioxidant and neuroprotective potential, this study evaluates whether oligo-porphyran (OP) could be beneficial in an experimental model of PD in mice. The drug 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was intraperitoneally injected (20 mg/kg body weight) for seven days to simulate PD, followed by OP administration. We found that the behavioral deficits in spontaneous motor activity, latency to descend in a pole test, and suspension in a traction test were ameliorated, and excessive dopamine (DA) metabolism was suppressed after OP treatment. Additionally, we found that OP protected dopaminergic neurons by preventing MPTP-induced decreases in dopaminergic transporter and tyrosine hydroxylase protein levels. We speculated whether OP regulates a signaling pathway that affects the behavioral changes seen in PD mice. In this study, the PI3K/Akt/Bcl-2 pathway was detected. Our results demonstrate that OP increased the phosphorylation of PI3K/Akt/GSK-3β and inhibited the activation of caspase-3 and poly (ADP-ribose) polymerase, with changes in the Bax/Bcl-2 ratio. These results showed that OP might promote DA neuron survival in vivo by regulating the PI3K/Akt/Bcl-2 pathway, thereby ameliorating the neurobehavioral deficits in a PD mouse model and suggesting OP as a neuroprotective treatment for PD.

18 January 2019 in Journal of Applied Phycology
Verified
Journal Article
Closed access
PDF file
YLYingjuan Liu
Yingjuan Liu
ZDZhenzhen Deng
Zhenzhen Deng
LGLihua Geng
Lihua Geng
JWJing Wang
Jing Wang
QZQuanbin Zhang
Quanbin Zhang